Welcome to new members of the ECMC Programme Office - February 2022
News
Over the past few months, we have welcomed four new members to the ECMC team. Lamise Nasr, Paediatric Network Manager; Molly Obadiah, Digital Healthcare Business Development Manager; Meghan Quirke, Website Executive Intern and Mollie Stebbings, Data Analyst (Clinical Trials). Find out more about them here.
New regulatory routes for cancer treatment in Britain
News
We're pleased to launch new and informative webpages that will help you navigate the new research regulatory landscape.
Regulatory routes for cancer treatment in Britain - Come early
Basic page
MHRA and Health Technology Appraisal (HTA) Advisory Support Advice from the Medicines Regulator : MHRA offers a variety of services including their innovation office. Early engagement is encouraged and scientific advice can be sought at any point in drug development and can be revisited throughout the development programme. Additional participants...
Regulatory routes for cancer treatment in Britain - Innovative Licensing and Access Pathway (ILAP)
Basic page
The most significant of these new routes to market authorisation is the Innovative Licensing and Access Pathway (ILAP) launched in January 2021 by National Institute for Health and Care Excellence (NICE) , the Scottish Medicines Consortium (SMC) , and later joined by the All Wales Therapeutics and Toxicology Centre (AWTTC)...
ECTF- Important this month
Basic page
Introduction This page is for EC Trial Finder coordinators and data managers. Here you can find key updates related to your monthly EC Trial Finder information submission. Below you can find 1) Notice on what is important for this month’s trial submission 2) Information about the Sponsor notification process and...
Accelerated Pathway for Early Phase Trials Update
News
Improving the efficiency of trial set-up and delivery has been identified as a key priority in the Saving and Improving Lives: The Future of UK Clinical Research Delivery, launched in 2021. The ECMC network has initiated, in partnership with the Health Research Authority (HRA), a project which aims to develop and test revised approaches to set-up of early-phase trials within the ECMC Network.
Welcome to new member of the ECMC Programme Office - May 2022
News
Earlier this year we welcomed Laura Danielson, Children and Young People’s Research Lead to the ECMC team. Laura takes over from Sheona Scales who is currently on secondment in the CRUK Cancer Grand Challenge team. Find out more about Laura.
EC Trial Finder Data Submission - FAQ and Troubleshooting
Basic page
Frequently Asked Questions 1. How should I list the trial arms? In the current set up of EC Trial Finder data entry we ask you to list different cohorts , but not arms. Cohort is a group of individuals who share a common trait e.g. cancer type and/or molecular marker...
JING: Training the Next Generation 2022
News
Hear about the 9th annual Junior Investigator Network Group (JING): Training the Next Generation event which took place in May 2022 in Sheffield.
The industry engagement work of the ECMC Programme Office
News
Read about the work of the ECMC Programme Office to promote the ECMC network externally and building relationships with not just with Pharma, Biotech, Medtech and CROs but with key stakeholders including our sites, regulators and the various teams within the NIHR infrastructure who engage with industry.